ELAN
Price
$13.52
Change
+$0.17 (+1.27%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
7.87B
48 days until earnings call
ZTS
Price
$157.78
Change
+$0.44 (+0.28%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
77.48B
49 days until earnings call
Interact to see
Advertisement

ELAN vs ZTS

Header iconELAN vs ZTS Comparison
Open Charts ELAN vs ZTSBanner chart's image
Elanco Animal Health
Price$13.52
Change+$0.17 (+1.27%)
Volume$86.37K
Capitalization7.87B
ZOETIS
Price$157.78
Change+$0.44 (+0.28%)
Volume$21.88K
Capitalization77.48B
ELAN vs ZTS Comparison Chart in %
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. ZTS commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ELAN: $13.35 vs. ZTS: $157.34)
Brand notoriety: ELAN and ZTS are both notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 58% vs. ZTS: 80%
Market capitalization -- ELAN: $7.87B vs. ZTS: $77.48B
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 4 bearish.
  • ZTS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а -4.57% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -4.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.32%. For the same industry, the average monthly price growth was +12.97%, and the average quarterly price growth was +98.79%.

Reported Earning Dates

ELAN is expected to report earnings on Aug 11, 2025.

ZTS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.32% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than ELAN($7.87B). ELAN YTD gains are higher at: 10.239 vs. ZTS (-2.812). ZTS has higher annual earnings (EBITDA): 3.67B vs. ELAN (-224M). ZTS has more cash in the bank: 2.04B vs. ELAN (352M). ELAN has less debt than ZTS: ELAN (5.77B) vs ZTS (6.76B). ZTS has higher revenues than ELAN: ZTS (8.54B) vs ELAN (4.42B).
ELANZTSELAN / ZTS
Capitalization7.87B77.5B10%
EBITDA-224M3.67B-6%
Gain YTD10.239-2.812-364%
P/E RatioN/A32.94-
Revenue4.42B8.54B52%
Total Cash352M2.04B17%
Total Debt5.77B6.76B85%
FUNDAMENTALS RATINGS
ELAN vs ZTS: Fundamental Ratings
ELAN
ZTS
OUTLOOK RATING
1..100
7282
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
8119
PRICE GROWTH RATING
1..100
4659
P/E GROWTH RATING
1..100
9468
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTS's Valuation (65) in the Pharmaceuticals Generic industry is in the same range as ELAN (90) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.

ZTS's Profit vs Risk Rating (77) in the Pharmaceuticals Generic industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ELAN (81) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew somewhat faster than ELAN’s over the last 12 months.

ELAN's Price Growth Rating (46) in the Agricultural Commodities Or Milling industry is in the same range as ZTS (59) in the Pharmaceuticals Generic industry. This means that ELAN’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's P/E Growth Rating (68) in the Pharmaceuticals Generic industry is in the same range as ELAN (94) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANZTS
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 15 days ago
63%
Bullish Trend 2 days ago
59%
Declines
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend 7 days ago
55%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DHI128.664.46
+3.59%
DR Horton
GPCR22.100.37
+1.70%
Structure Therapeutics
STNE14.960.10
+0.67%
StoneCo Ltd
RCKT2.63-0.07
-2.59%
Rocket Pharmaceuticals
VGAS3.43-0.13
-3.65%
Verde Clean Fuels

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-0.82%
VTRS - ELAN
41%
Loosely correlated
-0.23%
SNDL - ELAN
39%
Loosely correlated
-0.80%
ZTS - ELAN
38%
Loosely correlated
+0.11%
PAHC - ELAN
37%
Loosely correlated
+2.43%
ACET - ELAN
33%
Poorly correlated
-5.25%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.11%
VTRS - ZTS
44%
Loosely correlated
-0.23%
PAHC - ZTS
41%
Loosely correlated
+2.43%
AMRX - ZTS
38%
Loosely correlated
+1.21%
ELAN - ZTS
38%
Loosely correlated
-0.82%
PBH - ZTS
35%
Loosely correlated
+1.14%
More